1. Home
  2. UBX vs SWAG Comparison

UBX vs SWAG Comparison

Compare UBX & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • SWAG
  • Stock Information
  • Founded
  • UBX 2009
  • SWAG 1994
  • Country
  • UBX United States
  • SWAG United States
  • Employees
  • UBX N/A
  • SWAG N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • SWAG Advertising
  • Sector
  • UBX Health Care
  • SWAG Consumer Discretionary
  • Exchange
  • UBX Nasdaq
  • SWAG Nasdaq
  • Market Cap
  • UBX 24.6M
  • SWAG 20.2M
  • IPO Year
  • UBX 2018
  • SWAG 2021
  • Fundamental
  • Price
  • UBX $1.26
  • SWAG $1.18
  • Analyst Decision
  • UBX Strong Buy
  • SWAG
  • Analyst Count
  • UBX 3
  • SWAG 0
  • Target Price
  • UBX $9.00
  • SWAG N/A
  • AVG Volume (30 Days)
  • UBX 70.7K
  • SWAG 12.3K
  • Earning Date
  • UBX 11-04-2024
  • SWAG 11-26-2024
  • Dividend Yield
  • UBX N/A
  • SWAG N/A
  • EPS Growth
  • UBX N/A
  • SWAG N/A
  • EPS
  • UBX N/A
  • SWAG 0.00
  • Revenue
  • UBX N/A
  • SWAG $75,893,871.00
  • Revenue This Year
  • UBX N/A
  • SWAG $11.55
  • Revenue Next Year
  • UBX N/A
  • SWAG N/A
  • P/E Ratio
  • UBX N/A
  • SWAG $599.76
  • Revenue Growth
  • UBX N/A
  • SWAG 28.74
  • 52 Week Low
  • UBX $1.11
  • SWAG $1.02
  • 52 Week High
  • UBX $2.26
  • SWAG $1.74
  • Technical
  • Relative Strength Index (RSI)
  • UBX 47.73
  • SWAG 56.70
  • Support Level
  • UBX $1.11
  • SWAG $1.10
  • Resistance Level
  • UBX $1.37
  • SWAG $1.19
  • Average True Range (ATR)
  • UBX 0.08
  • SWAG 0.04
  • MACD
  • UBX 0.00
  • SWAG 0.01
  • Stochastic Oscillator
  • UBX 69.49
  • SWAG 78.50

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, It offer its clients with custom sourcing capabilities which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, and event assets, order and inventory management, and designing and hosting online retail popup shops. The company purchases products and branding through various third-party manufacturers and decorators and resells the finished goods to customers.

Share on Social Networks: